Abstract
Acute lower respiratory tract infection is a major health problem that affects more than 15% of the total population of Saudi Arabia each year. Epidemiological studies conducted over the last three decades have indicated that viruses are responsible for the majority of these infections. The epidemiology of respiratory viruses in Saudi Arabia is proposed to be affected mainly by the presence and mobility of large numbers of foreign workers and the gathering of millions of Muslims in Mecca during the Hajj and Umrah seasons. Knowledge concerning the epidemiology, circulation pattern, and evolutionary kinetics of respiratory viruses in Saudi Arabia are scant, with the available literature being inconsistent. This review summarizes the available data on the epidemiology and evolution of respiratory viruses. The demographic features associated with Middle East respiratory syndrome-related coronavirus infections are specifically analyzed for a better understanding of the epidemiology of this virus. The data support the view that continuous entry and exit of pilgrims and foreign workers with different ethnicities and socioeconomic backgrounds in Saudi Arabia is the most likely vehicle for global dissemination of respiratory viruses and for the emergence of new viruses (or virus variants) capable of greater dissemination.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Respiratory tract infections (RTIs) are detrimental to the health of individuals and economies. Millions of deaths due to acute lower RTIs (ARTIs) occur each year worldwide. The deaths commonly occur in premature infants, immunocompromised patients, individuals with bronchopulmonary dysplasia, and the elderly as a result of severe pneumonia. Children under 5 years of age are also vulnerable, with annual estimates of 1.9 [1], 10.8 [2] and [3] million deaths. Viruses are a major cause of ARTIs [4]. Human respiratory syncytial virus (HRSV) is the most frequent pathogen, followed by influenza viruses, human rhinovirus, enterovirus, human coronavirus, human parainfluenza viruses, and human metapneumoviruses [5]. In addition to these, newly emerging viruses, including severe acute respiratory syndrome-related coronavirus (SARS-CoV), Middle East respiratory syndrome-related coronavirus (MERS-CoV), and influenza viruses of swine (H1N1) and avian (H5N1, H7N9) origin are a threat to public health.
In Saudi Arabia, ARTI cases involved over 5 million (15.4%) of the population in 2013 [6]. The epidemiology, evolution, and circulation patterns of respiratory viruses in Saudi Arabia may be affected by two major factors. One is the presence of over 11.9 million foreign workers from more than 100 countries [7]. The movements of this huge number back and forth between their home nations and the Kingdom of Saudi Arabia may help to introduce new viral strains. The second factor is the gathering of more than 10 million Muslims from approximately 184 different countries in the holy sites of Mecca and Medina during the Hajj and Umrah seasons. Pilgrims and foreign workers are a large heterogeneous population in terms of ethnicity, underlying medical conditions, including a markedly variable rate of lower RTIs [8], and socioeconomic backgrounds. During the 3- to 4-day Hajj ritual, many pilgrims are confined in close proximity in tents and alleys [9, 10]. The overcrowding is ideal for the spread of respiratory viruses and is a major public health concern. Those who become infected can pass the respiratory viral infection on to others upon their return to their countries [11,12,13,14].
The circulation patterns of respiratory viruses in Saudi Arabia are unclear. This lack of clarity is due to the paucity of studies being done, the past focus on respiratory viruses present during the Hajj season, and the relative lack of information concerning the evolution and phylogeny of respiratory viruses, compared to virus detection. We have studied the prevalence, epidemiology, and phylogeny of several respiratory viruses, including influenza viruses [15, 16], parainfluenza viruses [17,18,19], HRSV [20, 21], human metapneumovirus [22], and others [23]. These data are discussed in the subsequent sections. Importantly, these data are mainly for respiratory viruses circulating in Riyadh.
The intent of the current review is to collect and present a full historical record of respiratory virus infections in the population of Saudi Arabia in terms of epidemiology, circulation pattern, genetic and phylogenetic analysis, and evolutionary perspectives. Moreover, epidemiologic and demographic features associated with MERS-CoV infections are addressed by analyzing the clinical data of 1549 laboratory-confirmed cases of MERS-CoV infections and by considering the camel-to-human and human-to-human transmission of MERS-CoV.
MERS-CoV
The virus
Viruses within the subfamily Orthocoronavirinae (family Coronaviridae, order Nidovirales) are grouped into four genera: Alpha-, Beta-, Gamma-, and Deltacoronavirus [24]. Six coronaviruses can infect humans: HCoV-229E, NL63, OC43, HKU1, SARS-CoV, and MERS-CoV. The first two belong to the genus Alphacoronavirus, and the remainder belong to the genus Betacoronavirus, with MERS-CoV belonging to lineage C [25]. CoVs are characterized by having the largest genome of RNA viruses (29–32 kb). The genome is single-stranded, positive-sense, and enclosed within particles with a corona-like morphology [26].
Epidemiology
The capability of CoVs to infect a wide range of hosts, including animals and humans, has been known for a long time. CoVs often cause mild and self-limited respiratory diseases in humans [27, 28]. However, CoVs received much attention after the SARS-CoV pandemic that began in mid-November of 2002 in Guangdong, China. The virus spread to several countries around the world and led to the death of 774 (9.56%) of 8,096 infected individuals reported to the World Health Organization (WHO) [29]. A SARS-like CoV identified as MERS-CoV was isolated from a Saudi patient in 2012. MERS-CoV quickly spread to neighboring countries, followed by a wider spread to geographically distant countries [25, 30, 31]. WHO statistics from January 2019 indicate that this outbreak involved 27 countries with 2,279 laboratory-confirmed cases and 806 deaths (35.3% case fatality rate). Saudi Arabia was the hotspot of the outbreak, with 1901 cases reported and 732 deaths (38.7% case fatality rate) [32].
In the spring of 2014, another outbreak occurred in Saudi Arabia. Up to 500 laboratory-confirmed cases were identified within a short period of time. The outbreak originated in Jeddah, with cases also detected at the same time in Riyadh, Al-Kharj, and Medina [33]. An attempt to study the epidemiology of MERS-CoV was made based on data collected from the Saudi Ministry of Health during 2012 to July 2015. The risk factors and case fatality rates among 939 MERS-CoV-infected individuals were analyzed [34]. To increase our understanding of MERS-CoV epidemiology, we analyzed the demographic data of 1549 MERS-CoV-confirmed cases. Data from May 2013 to March 2018 were retrieved from the Ministry of Health and statistically evaluated. The largest numbers of MERS-CoV cases were reported in 2014 (n = 523) and 2015 (n = 452) (Table 1). More recently, the number of hospital-acquired cases has dropped significantly due to improved control measures.
Among the regions of the kingdom (Fig. 1), the Central Region (Riaydh, Qasim) was the most affected area, followed by the Western Region (Mecca, Medina, Jeddah), Eastern Region (Damam, Khafji, Alhasa), Northern Region (Tabuk, Jouf, Hail), and Southern Region (Asir, Najran, Jizan) (Fig. 2). Except for August and September 2015, significant MERS-CoV peaks were observed between March and May of the remaining years (Fig. 3). Analysis of demographic data of patients revealed that 35% (n = 545) of those infected were 41 to 60 years of age, 32% (n = 495) were more than 60 years of age, 27% (n = 418) were 20 to 40 years of age, and 2% (n = 35) were younger than 20 years of age. Males (64%) were more frequently infected than females (32%). However, in a previous study, both sexes displayed the same mortality rate [35]. Co-morbidities, including diabetes, renal diseases, hypertension, and pulmonary diseases, were evident in 642 (41%) of the MERS-CoV cases (Table 1). A cross-sectional serologic survey of human serum samples collected from healthy individuals (>15 years of age) across all 13 provinces of Saudi Arabia was performed. MERS-CoV antibodies were detected only in 15 (0.15%) of 10,009 samples collected from blood donors and slaughterhouse workers. Up to 45,000 Saudis may be seropositive for MERS-CoV but asymptomatic [36]. Such individuals are potential sources for the spread of MERS-CoV.
Camel-to-human and human-to-human transmission of MERS-CoV
MERS-CoV has a wide species tropism, as the virus can replicate in a variety of mammalian cells of different origins [37]. This suggests that the virus originated from animals. As is the case with several beta-CoVs, bats are the common reservoir from which the virus jumped to humans through intermediate hosts [38]. MERS-CoV is thought to be transmitted to humans directly from bats or through an intermediate host, most likely dromedary camels [39,40,41]. Many studies have sought to define the animal reservoir, intermediate host(s), and the possibility of human-to-human transmission. Although bats are considered the ancestral reservoir of CoVs [42], camels are important for the maintenance and diversification of MERS CoVs, and they are the source of human infections. It has been estimated that camel exposure resulted in 12% of MERS-CoV infections [43]. A survey of MERS-CoV-infected individuals from 20 hospitals in Saudi Arabia revealed that some had direct contact with camels, while others had likely acquired the virus from infected humans [44]. The possibility of human-to-human transmission was also supported by the presence of hospital-associated outbreaks in several countries, including Saudi Arabia [30, 33, 45,46,47,48].
The transmission from camels to humans in several studies has indicated that camels are the most likely intermediate host for MERS-CoV. In one case in Saudi Arabia, a patient in contact with his infected camels was admitted to the intensive care unit of a hospital in Jeddah with respiratory dyspnea. The patient died 15 days after admission. The MERS-CoV isolates obtained from the patient and one of the camels were genetically identical [49]. Sequence similarity between MERS-CoV isolated from camels and humans has also been reported in other studies [50,51,52]. In a similar case, a 62-year-old man living in the Al-Hasa region was the source of an outbreak after likely acquiring the infection from a camel. He spread the infection to his family and three public hospitals, resulting in 52 cases and 18 deaths [53]. In other studies, MERS-CoV was detected in serum samples collected from camels throughout Saudi Arabia, while specific antibodies were not detected in domestic sheep, goats, cows, or equids [39, 54, 55]. Viral RNA was also detected in camels’ milk [56]. In another study, virus replication, shedding, and persistence were evaluated by infecting dromedary camels intranasally, intratracheally, and conjunctively. Infected camels shed high titers of virus for 7 days post-inoculation, and viral RNA was detected on day 35 post-inoculation [57]. Coinfection with MERS-CoV and other coronaviruses (i.e., non-MERS viruses) has been documented. Two non-MERS-related CoVs were isolated with sequence similarity to human coronaviruses 229E and OC43 [58].
From the above findings, it is clear that camels play a key role in maintenance, divergence, and transmission of MERS CoVs. However, two points require further investigation. Firstly, MERS-CoV-specific antibodies were detected in archival samples collected from dromedary camels in Saudi Arabia during 1992 to 2010. Similarly, a high percentage of archived samples collected since 1983 from camels in eastern Africa were found to contain MERS-CoV-neutralizing antibodies (153/189) [59]. These findings indicate the high prevalence of MERS-CoV in camels, but it is not clear why camel-to-human transmission occurred only during 2012 and not before. Secondly, MERS-CoV antibodies were detected in camels from Egypt, Jordan, Egypt, Nigeria, Ethiopia, Kenya, Burkina Faso, Morocco, Tunisia, and Spain [50, 51, 60,61,62], but camel-to-human transmission has been reported only in Saudi Arabia.
Influenza viruses
The virus
Influenza viruses are members of the family Orthomyxoviridae. This family includes viruses with a single-stranded, negative-sense, segmented RNA genome [63]. Based on variations in the nucleoprotein and matrix proteins, orthomyxoviruses are classified into seven different genera: Alphainfluenzavirus (influenza A virus), Betainfluenzavirus (influenza B virus), Deltainfluenzavirus (influenza D virus), Gammainfluenzavirus (influenza C virus), Thogotovirus, Quaranjavirus, and Isavirus [64]. Among the orthomyxoviruses, influenza A viruses, the most important causative agents of flu pandemics, are classified into several antigenic subtypes based on their hemagglutinin (H,18 subtypes) and neuraminidase (N, 11 subtypes) surface proteins [65].
Epidemiology
Influenza viruses are highly contagious pathogens. They infect a wide range of hosts, such as birds, humans, pigs, horses [66], cats, and whales [67]. Worldwide, influenza A viruses have caused serious and massive pandemics where millions of cases have been reported with high mortality rates. Moreover, these viruses strongly affect the economies of developing and developed countries. In the United States, the annually estimated cost of treatment exceeds $10 billion [68]. Several influenza A virus subtypes have caused serious human pandemics. Influenza A H2N2 virus was responsible for the Asian/Russian pandemic that killed approximately one million humans in 1889. The virus re-emerged in 1957 and killed approximately 2 million people. Influenza A H1N1 virus, the causative agent of Spanish flu, caused approximately 500 million infections and approximately 50 million deaths in 1918. An H1N1 outbreak dubbed “swine flu” began in 2009 and continues to cause epidemics with high morbidity and mortality rates [69]. The ability of influenza A virus to evolve and to cross species barriers has resulted in the emergence of new subtypes, including H7N9 [70], H10N8 [71], H17N10, and H18N11[65].
The Saudi Ministry of Health established a surveillance program for influenza viruses [72]. Several issues concerning epidemiology, antigenicity, and genetic diversity still need to be clarified. In 2009, a novel H1N1 virus originating in swine was first identified in Mexico. The virus spread rapidly and caused a pandemic with more than 22 million cases in the United States. The mortality rate was low (0.5%) in comparison with seasonal influenza strains [73]. Saudi Arabia was one of the countries affected by the virus, with 15,850 laboratory-confirmed cases and 124 deaths by December 2009 [74]. The first 100 cases in Saudi Arabia involved Saudis and Filipino travelers at King Khaled Airport during June 2009 [74]. Between July and September, H1N1 was detected in patients with influenza-like illnesses treated at King Khaled University Hospital in Riyadh [75]. In Riyadh, a prospective 6-month cohort study from July to December of 2009 included 1103 children (0-12 years of age) with influenza-like illness. Of these, 375 (34%) tested positive for H1N1, and 50 (13.3%) were hospitalized [76].
During October and November, 2010, 12 (57%) patients hospitalized at Prince Mansour Military Hospital in Taif were H1N1 positive, and two patients died [77]. In Hail City, a retrospective study conducted throughout 2015 at King Khaled Hospital revealed 54 (18%) infections with H1N1 pdm09. The patients ranged in age from 7 months to 85 years [78]. In a prospective study conducted from June to November of 2009, 526 health care workers at King Abdul-aziz Medical City (Riyadh) tested positive for H1N1 pdm09 [79]. In another prospective study conducted from July 2009 to June 2010 at a tertiary-care hospital in Khamis Mushyt, 117 laboratory-confirmed cases of influenza A H1N1 pdm09 were reported. Forty-seven patients developed pneumonia, 22 were admitted to the intensive care unit, and 22 died [80]. Another study documented 47 laboratory-confirmed influenza A H1N1 pdm09 cases among hospitalized patients in a Saudi Arabian hospital [81]. These findings indicate the circulation and indigenous transmission of influenza A H1N1 pdm09 virus in Saudi Arabia.
HRSV
The virus
HRSV is a member of the genus Orthopneumovirus, family Pneumoviridae, order Mononegavirales, phylum Negarnaviricota [64]. This order includes viruses with a negative-sense, non-segmented, and single-stranded RNA genome [82, 83]. The HRSV genome ranges from 15,191 to 15,226 nucleotides in length [84] and codes for ten subgenomic mRNAs [85]. Based on the heterogeneity of the attachment glycoprotein gene, HRSV strains are classified antigenically into A and B subgroups [86].
Epidemiology
HRSV is a highly contagious virus that causes lower RTIs in humans of different ages. One study described the infection of 33.8 million children, with 3.4 million hospitalizations and nearly 199,000 deaths. Almost all (99%) of the cases were reported from developing countries [87]. In addition, HRSV infections have a great economic impact, with annual direct medical costs having been estimated at $650 million in the United States alone [88]. Neonates and infants under 5 years of age are more prone to severe and even fatal HRSV infections [23]. Similarly, individuals with underlying risk factors, such as prematurity, bronchopulmonary dysplasia (BPD), and congenital heart disease, and those with natural or induced immunodeficiency are at high risk of severe HRSV infection [89].
In comparison with other respiratory viruses, HRSV is the leading cause of lower RTIs in community and hospital studies [90, 91]. The virus is responsible for a high percentage of hospital admissions of babies [92]. Evolution of new genotypes of HRSV strains usually leads to recurrent infections in infants [93]. However, subsequent infections in adults are generally less severe and are usually asymptomatic [94]. The seasonality of HRSV epidemics is influenced by a number of factors, including climate, geographical region, virus dynamics, and social behavior. The epidemic period may extend for 1 to 5 months, depending on the geographic region involved [95, 96]. Both group A and group B HRSV can co-circulate during epidemics, with group A isolates often being more prevalent than group B [20, 95, 97]. However, there is a regular change of the circulating strains/groups and emergence/disappearance of new lineages [98].
Several studies have been conducted in Saudi Arabia to detect HRSV in clinical samples collected from hospitalized patients in different provinces (Table 2). These studies utilized immunofluorescence, ELISA, conventional RT-PCR, and real-time PCR assays and produced highly variable results, ranging from 4.7% to 83%. The prevalence of HRSV was generally high and usually was the leading cause of viral respiratory disease. In our laboratory, the circulation patterns of both groups of HRSV were examined. In addition, the virus was isolated and characterized for the first time in Saudi Arabia. Moreover, the genetic diversity, molecular and phylogenetic analysis of group A and B HRSV were studied [20, 21]. Based on sequence analysis of the second hypervariable region of the G gene, we found that all Saudi HRSV B strains belonged to the genotype BA, which is characterized by a 60-nucleotide duplication.
The predominant genotype of HRSV A during 2007/08 and 2008/09 was NA1 [21]. Recently, we reported the circulation of the ON1 genotype in Saudi Arabia during 2014/15 and 2015/16 (unpublished data, GenBank accession numbers MH388029 to MH388042). This genotype is characterized by a 72-nucleotide duplication in the C-terminal region of the G gene. ON1 was first detected in Ontario, Canada [99], and was subsequently reported in several other countries. The demographic features associated with virus infection were also investigated. Infants younger than 6 months of age are the most affected age group, and males are infected more often than females [21]. In Saudi Arabia, HRSV infection tends to peak from October to March [23, 100, 101].
Human parainfluenza viruses (HPIVs)
The virus
PIVs are members of the family Paramyxoviridae, order Mononegavirales. There are four genetically and antigenically different HPIVs distributed in two genera. The genus Respirovirus includes human respirovirus 1 (formerly HPIV-1) and human respirovirus 3 (formerly HPIV-3). The genus Orthorubulavirus includes human orthorubulavirus 2 (formerly HPIV-2) and human orthorubulavirus 4 (formerly HPIV-4) [102]. The genome of HPIV is single-stranded, non-segmented, and negative-sense and ranges in size from 15,300 to 17,400 nucleotides. The genome is enclosed within an enveloped helical nucleocapsid.
Epidemiology
HPIVs are important human pathogens causing acute upper and lower RTIs with varying degrees of severity. Of the four types, HPIV-1, -2, and -3 have been frequently detected in RTI outbreaks, particular in institutional settings [18, 19, 103]. HPIV-4 causes mild respiratory symptoms and has not been frequently detected in outbreaks and is therefore regarded as a less clinically important strain [104,105,106]. HPIV infections are characterized by croup (acute laryngotracheobronchitis), bronchiolitis, pneumonia, tracheobronchitis, and febrile and afebrile wheezing [101]. In the USA and the United Kingdom, the epidemiology of HPIV has been elucidated. In the USA, HPIVs account for approximately 1.7 million annual infections in children younger than 5 years of age [107, 108]. They are also responsible for up to 17% of hospitalizations caused by acute RTIs in children younger than 5 years of age [109, 110]. In the UK, a retrospective study including 8221 PIV-infected cases over a 12-year period revealed that HPIV-1, -2, -3 and -4 accounted for 17.2%, 70.8%, 7.5%, and 1.1%, respectively, of the reported cases. Of these cases, 64.1% were infants under one year of age, 24.4% were children aged 1 to 4 years, and 7.2% were patients aged 5 years or older [111].
HPIV infections are detected throughout the year at low frequency [112]. Seasonal patterns vary based on the virus type. The reason for the variation is unclear and may involve climate change [107]. HPIV-1 and HPIV-2 have been reported to cause biennial fall epidemics and may circulate concurrently with HPIV-2, causing annual outbreaks [113]. Spring and summer epidemics of HPIV-3 have been reported in North America and Europe [102].
In Saudi Arabia, data concerning the epidemiology of HPIV are scarce. The circulation of HPIVs was documented in a number of provinces, including Abha, Qassim, and Riyadh [101, 114,115,116]. In Riyadh, a total of 1429 Saudi children were admitted to King Khaled University Hospital between April 1993 and March 1996 with RTIs. Among these, 522 (37%) were identified to be caused by viruses. HPIV-3 was detected in 42 cases (8%). The authors also reported that HPIV-3 could be detected in all months, with epidemics during June to August, when the air temperature was 40 °C [18]. In another study, HPIVs were detected in nasopharyngeal aspirates collected from infants and young children admitted to the Buraidah Maternity and Pediatric Hospital, Al-Qassim, Saudi Arabia, during the winter season of 2003/2004. Among 282 screened samples, the frequency of HPIV-1, -2, and -3 was 9 (3.2%), 4 (1.4 %), and 1 (0.4 %), respectively [116].
In our laboratory, the circulation pattern of HPIVs in Saudi patients treated at King Khaled University Hospital was examined. HPIVs in nasopharyngeal aspirates collected from hospitalized children during two consecutive seasons (2007/08 and 2008/09) were screened using RT-PCR. Of 180 samples, 10 (5.56%) contained HPIV-3 [18] and contained (0.56%) was HPIV-2 [18]. In addition, we investigated the genetic characteristics and phylogeny of Saudi HPIV-3 strains by sequencing the entire hemagglutinin-neuraminidase gene. HPIV-3 strains displayed sequence similarity to strains from India, China, and Japan. A distinct Asian lineage was inferred from phylogenetic analysis [17, 19]. Phylogenetic analysis showed that a Saudi strain of HPIV-2 was related to a strain reported in the US state of Oklahoma [18].
Other respiratory viruses
Human metapneumovirus (hMPV), a member of the family Pneumoviridae, is an enveloped virus with a negative-sense, non-segmented and single-stranded RNA genome. The virus was first reported in 2001 and was identified as a common cause of upper and lower RTIs in young children, the elderly, and immune-compromised individuals. The virus is responsible for approximately 5% to 10% of hospitalizations of children due to severe bronchiolitis and pneumonia. We investigated the epidemiology and genetic diversity of hMPV in Saudi children hospitalized in Riyadh. The virus was detected in 19 (10.9%) of 174 nasopharyngeal airway samples and was found to be the third major cause of RTI after HRSV (n = 39, 22.4%) and influenza A virus (n = 34, 19.5%). Males (n = 14, 73.7%) were more frequently infected than females (n = 5, 26.3%). Children younger than 2 years of age were the most affected group [23].
To identify hMPV lineages circulating in Riyadh, phylogenetic analysis was performed using the full-length G gene and a partial sequence of the F gene. We found that all hMPV subgenotypes and lineages, except A1, circulated in Riyadh [22]. Worldwide, hMPV usually peaks in winter and spring [117, 118]. In Saudi Arabia, the epidemiology data of hMPV are very limited [119, 120]. hMPV usually has broad seasonal peaks. In one study, the virus was most frequently reported from January to March [23], while another study reported hMPV peaks in March, August, and September [119]. Some other studies that reported the prevalence of hMPV in Saudi Arabia are listed in Table 3.
Human rhinovirus, a member of the family Picornaviridae, has a single-stranded, positive-sense RNA genome enclosed within a naked capsid. HRV has been reported to cause upper RTIs and some lower RTIs in children [121]. Epidemiological studies in Saudi Arabia have shown that hRV infects people of all ages [119, 120].
Another causative agent of viral RTIs is human adenovirus (hAdV). It is a double standard, non-enveloped DNA virus with more than 50 serotypes. The virus has no seasonal variation and can infect humans throughout the year. hAdV accounts for 5% to 10% of acute lower RTIs in children [122, 123]. In Saudi Arabia, one study reported that children 1-3 years of age were infected more frequently than younger or older children [114]. Table 3 summarizes data concerning hMPV, hAdV, hRV, HCoV, and bocavirus RTIs in Saudi Arabia.
Respiratory viruses and the Hajj season
Detection of respiratory viruses in pilgrims
During the Hajj season, acute respiratory infections account for 57% of hospitalizations [124,125,126,127]. Detection of respiratory viruses among more than 14,000 pilgrims over seven consecutive Hajj seasons has revealed that influenza A viruses were the most frequently detected viruses, followed by HRSV, HPIVs, rhinoviruses, non-MERS CoVs, and metapneumoviruses [128]. Therefore, studying respiratory viruses circulating among pilgrims is important to prevent serious consequences, particularly with elderly and immunocompromised individuals. To investigate nasal carriage of MERS-CoV among Hajj pilgrims, 5235 nasopharyngeal samples were collected from pilgrims of 22 countries pre- and post-Hajj. Samples were screened by PCR. None of the tested samples were positive [129]. Similarly, MERS-CoV was not detected in Hajj returnees to France [14], Austria [130], North India [131], China [132], Jordan [133], Egypt [134], or Qatar [135]. These findings do not exclude the possibility of human-to-human transmission.
Several studies were also carried out to detect influenza viruses circulating during the Hajj seasons [136,137,138,139,140]. In these studies, the virus was detected in different types of samples, including throat swabs, nasal swabs, nasopharyngeal swabs, sputum, bronchoalveolar and nasopharyngeal aspirates, gargled pharyngeal secretions, and serum. These studies do not reflect the real situation of influenza in the kingdom because they are mainly focused on pilgrims. In addition, these studies included pilgrims of different nationalities [12, 52, 127, 130, 141,142,143]. H1N1 was detected among pilgrims of the 2009 Hajj season [144]. In a prospective cohort study during the 2009 Hajj season, 110 critically ill patients in four hospitals were involved. Of these, 11 (10%) displayed severe H1N1 infections [145]. In Mecca and during the Hajj season of 2010, 120 (7.5%) of 1,500 pilgrims were confirmed to have H1N1 pdm09 infection [137]. Similarly, HRSV [140, 142, 143, 146,147,148] and HPIVs [12, 14, 135, 139, 148, 149] were frequently detected during the Hajj season.
Transmission of respiratory viruses beyond the Hajj season
During the Hajj season, millions of Muslims gather in Mecca in the largest annual mass congregation worldwide. In such overcrowded conditions, respiratory viruses spread easily. Several studies have documented the increased rate of viral respiratory infections among pilgrims [12, 135, 141, 143, 146]. Upon return to their home countries, pilgrims act as potential foci for spread of new viruses among susceptible populations. Transmission of these viruses in a so-called ‘virgin soil’ has serious consequences and may result in global outbreaks and/or pandemics (examples: MERS-CoV and influenza A viruses). Therefore, several countries routinely screen Hajj returnees, particularly those developing or showing signs of respiratory illness. For instance, influenza virus was identified in 64% of the pilgrims returning to France after the Hajj season of 2011/2012 [150]. In prospective studies on French pilgrims, a significantly higher percentage of returning pilgrims had respiratory virus infections than before travelling to Saudi Arabia [12, 151].
In the UK, among 202 returning pilgrims/travelers, 28 (13.8%) were infected with influenza A virus, 13 (6.4%) with influenza B virus, 29 (14%) with rhinovirus, 10 (4.9%) with parainfluenza viruses, 10 (4.9%) with adenovirus, five (2.4%) with RSV, and three (1.4%) with human metapneumovirus [152]. In Ghana, a total of 651 out of 839 (77.6%) returning pilgrims were suffering from ARTIs. Rhinovirus was detected in 141 returnees, RSV in 43, and influenza A virus in 11. Coinfection with more than one respiratory virus was reported in 1.9% of the tested returnees [147]. In Iran, a total of 275 (out of 3000) pilgrim returnees with flu-like symptoms were tested. Influenza A viruses were detected in 13 (8 H1N1 and 5 H3N2), and 20 tested positive for influenza B virus [142]. In Austria, five pilgrims were influenza positive and two were infected by rhinovirus [130]. In India, 22 hajj returnees tested positive for influenza A virus (13 H3N2 and 9 H1N1), and 11 were positive for influenza B/Yamagata [131].
From the above-mentioned studies, it is clear that rhinoviruses and influenza viruses (A and B) are the most prominent among Hajj returnees. The absence of MERS-CoV among Hajj returnees does not exclude the possibility of its nasal carriage to other countries. Studies performed before, during and after the Hajj season support the notion that pilgrimage contributes to the epidemiology of respiratory viruses. Hajj returnees could also transmit these viruses into different parts of Saudi Arabia through domestic pilgrims or globally through international pilgrims. Therefore, it is recommended for pilgrims to follow the vaccination regimen approved by the Saudi Ministry of Health and CDC.
Conclusions
In an era of rapid global travel, viruses have no borders and can traverse countries and even continents within a few hours. Airports and other ports of entry to Saudi Arabia witness a dynamic movement of millions of pilgrims and foreign workers throughout the year. These huge numbers of people have different ethnicities, underlying clinical conditions, and socioeconomic backgrounds. They vary in their susceptibility to respiratory virus infections and represent a potential source of virus transmission to the Kingdom of Saudi Arabia. Control measures at different ports of entry are a prudent strategy, particularly during the winter and Hajj seasons. In addition, pilgrims should be advised to follow vaccination programs before performing the Hajj ritual. This will help to reduce the spread of virus beyond the Hajj season, both to other parts of Saudi Arabia by domestic pilgrims and to other countries by international pilgrims. More research studies that clarify the epidemiology, phylogeny, and evolution of respiratory viruses are urgently required to predict and reduce the impact of future epidemics.
References
Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C (2002) Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2:25–32
Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P, Campbell H, Walker CF, Cibulskis R, Eisele T, Liu L, Mathers C, Child Health Epidemiology Reference Group of WHO, Unicef (2010) Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375:1969–1987
Bryce J, Boschi-Pinto C, Shibuya K, Black RE, Group WHOCHER (2005) WHO estimates of the causes of death in children. Lancet 365:1147–1152
Fahey T, Stocks N, Thomas T (1998) Systematic review of the treatment of upper respiratory tract infection. Arch Dis Child 79:225–230
Raymond F, Carbonneau J, Boucher N, Robitaille L, Boisvert S, Wu WK, De Serres G, Boivin G, Corbeil J (2009) Comparison of automated microarray detection with real-time PCR assays for detection of respiratory viruses in specimens obtained from children. J Clin Microbiol 47:743–750
Fagbo SF, Garbati MA, Hasan R, AlShahrani D, Al-Shehri M, AlFawaz T, Hakawi A, Wani TA, Skakni L (2017) Acute viral respiratory infections among children in MERS-endemic Riyadh, Saudi Arabia, 2012–2013. J Med Virol 89:195–201
Ministry of labor and social development (2016) Saudi Arabia labor market report 2016, 3rd edn. Kingdom of Saudi Arabia
Simpson CR, Steiner MF, Cezard G, Bansal N, Fischbacher C, Douglas A, Bhopal R, Sheikh A, researchers S (2015) Ethnic variations in morbidity and mortality from lower respiratory tract infections: a retrospective cohort study. J R Soc Med 108:406–417
Ahmed QA, Memish ZA (2016) Hajj 2016: Required vaccinations, crowd control, novel wearable tech and the Zika threat. Travel Med Infect Dis 14:429–432
Balaban V, Stauffer WM, Hammad A, Afgarshe M, Abd-Alla M, Ahmed Q, Memish ZA, Saba J, Harton E, Palumbo G, Marano N (2012) Protective practices and respiratory illness among US travelers to the 2009 Hajj. J Travel Med 19:163–168
Al-Tawfiq JA, Zumla A, Memish ZA (2013) Respiratory tract infections during the annual Hajj: potential risks and mitigation strategies. Curr Opin Pulm Med 19:192–197
Benkouiten S, Charrel R, Belhouchat K, Drali T, Nougairede A, Salez N, Memish ZA, Al Masri M, Fournier PE, Raoult D, Brouqui P, Parola P, Gautret P (2014) Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis 20:1821–1827
Charrel RN (2014) Hajj, Umrah, and other mass gatherings: which pathogens do you expect? Beware of the tree that hides the forest! Travel Med Infect Dis 12:418–419
Gautret P, Charrel R, Benkouiten S, Belhouchat K, Nougairede A, Drali T, Salez N, Memish ZA, Al Masri M, Lagier JC, Million M, Raoult D, Brouqui P, Parola P (2014) Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis 20:728–730
Almajhdi FN (2009) A report on the association of influenza B virus with respiratory tract infection of hospitalized children in Saudi Arabia. Saudi J Biol Sci 16:109–111
Almajhdi FN, Ali G (2013) Report on influenza A and B viruses: their coinfection in a Saudi leukemia patient. Biomed Res Int 2013:290609
Almajhdi FN (2015) Hemagglutinin-neuraminidase gene sequence-based reclassification of human parainfluenza virus 3 variants. Intervirology 58:35–40
Almajhdi FN, Alshaman MS, Amer HM (2012) Human parainfluenza virus type 2 hemagglutinin-neuramindase gene: sequence and phylogenetic analysis of the Saudi strain Riyadh 105/2009. Virol J 9:316
Almajhdi FN, Alshaman MS, Amer HM (2012) Molecular characterization and phylogenetic analysis of human parainfluenza virus type 3 isolated from Saudi Arabia. J Med Virol 84:1304–1311
Almajhdi FN, Farrag MA, Amer HM (2014) Group B strains of human respiratory syncytial virus in Saudi Arabia: molecular and phylogenetic analysis. Virus Genes 48:252–259
Almajhdi FN, Farrag MA, Amer HM (2014) Genetic diversity in the G protein gene of group A human respiratory syncytial viruses circulating in Riyadh, Saudi Arabia. Arch Virol 159:73–81
Amer HM (2016) Molecular epidemiology of human metapneumovirus in Riyadh Province, Saudi Arabia. J Mol Microbiol Biotechnol 26:414–421
Amer HM, Alshaman MS, Farrag MA, Hamad ME, Alsaadi MM, Almajhdi FN (2016) Epidemiology of 11 respiratory RNA viruses in a cohort of hospitalized children in Riyadh, Saudi Arabia. J Med Virol 88:1086–1091
Lu G, Liu D (2012) SARS-like virus in the Middle East: a truly bat-related coronavirus causing human diseases. Protein Cell 3:803–805
Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814–1820
Yao Q, Masters PS, Ye R (2013) Negatively charged residues in the endodomain are critical for specific assembly of spike protein into murine coronavirus. Virology 442:74–81
Perlman S (1998) Pathogenesis of coronavirus-induced infections. Review of pathological and immunological aspects. Adv Exp Med Biol 440:503–513
Weiss SR, Navas-Martin S (2005) Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev 69:635–664
WHO (2005) Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003, 2005. http://www.who.int/csr/sars/country/table2004_04_21/en/. Accessed 14 Nov 2014
Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF, Makhdoom HQ, Zumla AI, Memish ZA (2013) Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 13:752–761
Cauchemez S, Van Kerkhove MD, Riley S, Donnelly CA, Fraser C, Ferguson NM (2013) Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart. Euro Surveill 18(24):20503
WHO (2018) Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/. Accessed 14 Nov 2014
Drosten C, Muth D, Corman VM, Hussain R, Al Masri M, HajOmar W, Landt O, Assiri A, Eckerle I, Al Shangiti A, Al-Tawfiq JA, Albarrak A, Zumla A, Rambaut A, Memish ZA (2015) An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014. Clin Infect Dis 60:369–377
Alsahafi AJ, Cheng AC (2016) The epidemiology of Middle East respiratory syndrome coronavirus in the Kingdom of Saudi Arabia, 2012–2015. Int J Infect Dis 45:1–4
Alsahafi AJ, Cheng AC (2016) Knowledge, attitudes and behaviours of healthcare workers in the Kingdom of Saudi Arabia to MERS coronavirus and other emerging infectious diseases. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph13121214
Muller MA, Meyer B, Corman VM, Al-Masri M, Turkestani A, Ritz D, Sieberg A, Aldabbagh S, Bosch BJ, Lattwein E, Alhakeem RF, Assiri AM, Albarrak AM, Al-Shangiti AM, Al-Tawfiq JA, Wikramaratna P, Alrabeeah AA, Drosten C, Memish ZA (2015) Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis 15:629
Chan JF, Chan KH, Kao RY, To KK, Zheng BJ, Li CP, Li PT, Dai J, Mok FK, Chen H, Hayden FG, Yuen KY (2013) Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect 67:606–616
Lau SK, Li KS, Huang Y, Shek CT, Tse H, Wang M, Choi GK, Xu H, Lam CS, Guo R, Chan KH, Zheng BJ, Woo PC, Yuen KY (2010) Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events. J Virol 84:2808–2819
Alagaili AN, Briese T, Mishra N, Kapoor V, Sameroff SC, Burbelo PD, de Wit E, Munster VJ, Hensley LE, Zalmout IS, Kapoor A, Epstein JH, Karesh WB, Daszak P, Mohammed OB, Lipkin WI (2014) Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio 5:e00884-14
Lau SK, Li KS, Tsang AK, Lam CS, Ahmed S, Chen H, Chan KH, Woo PC, Yuen KY (2013) Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J Virol 87:8638–8650
Meyer B, Muller MA, Corman VM, Reusken CB, Ritz D, Godeke GJ, Lattwein E, Kallies S, Siemens A, van Beek J, Drexler JF, Muth D, Bosch BJ, Wernery U, Koopmans MP, Wernery R, Drosten C (2014) Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis 20:552–559
Hu B, Ge X, Wang LF, Shi Z (2015) Bat origin of human coronaviruses. Virol J 12:221
Cauchemez S, Nouvellet P, Cori A, Jombart T, Garske T, Clapham H, Moore S, Mills HL, Salje H, Collins C, Rodriquez-Barraquer I, Riley S, Truelove S, Algarni H, Alhakeem R, AlHarbi K, Turkistani A, Aguas RJ, Cummings DA, Van Kerkhove MD, Donnelly CA, Lessler J, Fraser C, Al-Barrak A, Ferguson NM (2016) Unraveling the drivers of MERS-CoV transmission. Proc Natl Acad Sci USA 113:9081–9086
Alhakeem RF, Midgley CM, Assiri AM, Alessa M, Al Hawaj H, Saeed AB, Almasri MM, Lu X, Abedi GR, Abdalla O, Mohammed M, Algarni HS, Al-Abdely HM, Alsharef AA, Nooh R, Erdman DD, Gerber SI, Watson JT (2016) Exposures among MERS case–patients, Saudi Arabia, January–February 2016. Emerg Infect Dis 22:2020–2022
Al-Abdallat MM, Payne DC, Alqasrawi S, Rha B, Tohme RA, Abedi GR, Al Nsour M, Iblan I, Jarour N, Farag NH, Haddadin A, Al-Sanouri T, Tamin A, Harcourt JL, Kuhar DT, Swerdlow DL, Erdman DD, Pallansch MA, Haynes LM, Gerber SI, Jordan M-CIT (2014) Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis 59:1225–1233
Bin SY, Heo JY, Song MS, Lee J, Kim EH, Park SJ, Kwon HI, Kim SM, Kim YI, Si YJ, Lee IW, Baek YH, Choi WS, Min J, Jeong HW, Choi YK (2016) Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea. Clin Infect Dis 62:755–760
Guery B, Poissy J, el Mansouf L, Sejourne C, Ettahar N, Lemaire X, Vuotto F, Goffard A, Behillil S, Enouf V, Caro V, Mailles A, Che D, Manuguerra JC, Mathieu D, Fontanet A, van der Werf S, group ME-Cs (2013) Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet 381:2265–2272
Gulland A (2013) Novel coronavirus spreads to Tunisia. BMJ 346:f3372
Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS, Hashem AM, Madani TA (2014) Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 370:2499–2505
Chu H, Zhou J, Wong BH, Li C, Cheng ZS, Lin X, Poon VK, Sun T, Lau CC, Chan JF, To KK, Chan KH, Lu L, Zheng BJ, Yuen KY (2014) Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response. Virology 454–455:197–205
Haagmans BL, Al Dhahiry SH, Reusken CB, Raj VS, Galiano M, Myers R, Godeke GJ, Jonges M, Farag E, Diab A, Ghobashy H, Alhajri F, Al-Thani M, Al-Marri SA, Al Romaihi HE, Al Khal A, Bermingham A, Osterhaus AD, AlHajri MM, Koopmans MP (2014) Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis 14:140–145
Memish ZA, Cotten M, Meyer B, Watson SJ, Alsahafi AJ, Al Rabeeah AA, Corman VM, Sieberg A, Makhdoom HQ, Assiri A, Al Masri M, Aldabbagh S, Bosch BJ, Beer M, Muller MA, Kellam P, Drosten C (2014) Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis 20:1012–1015
El Bushra HE, Abdalla MN, Al Arbash H, Alshayeb Z, Al-Ali S, Latif ZA, Al-Bahkit H, Abdalla O, Mohammed M, Al-Abdely H, Chahed M, Lohiniva AL, Saeed AB (2016) An outbreak of Middle East Respiratory Syndrome (MERS) due to coronavirus in Al-Ahssa Region, Saudi Arabia, 2015. East Mediterr Health J 22:468–475
Meyer B, Garcia-Bocanegra I, Wernery U, Wernery R, Sieberg A, Muller MA, Drexler JF, Drosten C, Eckerle I (2015) Serologic assessment of possibility for MERS-CoV infection in equids. Emerg Infect Dis 21:181–182
Reusken CB, Haagmans BL, Muller MA, Gutierrez C, Godeke GJ, Meyer B, Muth D, Raj VS, Smits-De Vries L, Corman VM, Drexler JF, Smits SL, El Tahir YE, De Sousa R, van Beek J, Nowotny N, van Maanen K, Hidalgo-Hermoso E, Bosch BJ, Rottier P, Osterhaus A, Gortazar-Schmidt C, Drosten C, Koopmans MP (2013) Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis 13:859–866
Reusken CB, Farag EA, Jonges M, Godeke GJ, El-Sayed AM, Pas SD, Raj VS, Mohran KA, Moussa HA, Ghobashy H, Alhajri F, Ibrahim AK, Bosch BJ, Pasha SK, Al-Romaihi HE, Al-Thani M, Al-Marri SA, AlHajri MM, Haagmans BL, Koopmans MP (2014) Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014. Euro Surveill. https://doi.org/10.2807/1560-7917.ES2014.19.23.20829
Adney DR, van Doremalen N, Brown VR, Bushmaker T, Scott D, de Wit E, Bowen RA, Munster VJ (2014) Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels. Emerg Infect Dis 20:1999–2005
Sabir JS, Lam TT, Ahmed MM, Li L, Shen Y, Abo-Aba SE, Qureshi MI, Abu-Zeid M, Zhang Y, Khiyami MA, Alharbi NS, Hajrah NH, Sabir MJ, Mutwakil MH, Kabli SA, Alsulaimany FA, Obaid AY, Zhou B, Smith DK, Holmes EC, Zhu H, Guan Y (2016) Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science 351:81–84
Muller MA, Corman VM, Jores J, Meyer B, Younan M, Liljander A, Bosch BJ, Lattwein E, Hilali M, Musa BE, Bornstein S, Drosten C (2014) MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997. Emerg Infect Dis 20:2093–2095
Corman VM, Olschlager S, Wendtner CM, Drexler JF, Hess M, Drosten C (2014) Performance and clinical validation of the RealStar MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNA. J Clin Virol 60:168–171
Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, Siu LY, Shehata MM, Kayed AS, Moatasim Y, Li M, Poon LL, Guan Y, Webby RJ, Ali MA, Peiris JS, Kayali G (2013) Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. https://doi.org/10.2807/1560-7917.ES2013.18.36.20574
Sikkema RS, Farag E, Himatt S, Ibrahim AK, Al-Romaihi H, Al-Marri SA, Al-Thani M, El-Sayed AM, Al-Hajri M, Haagmans BL, Koopmans MPG, Reusken C (2017) Risk factors for primary middle east respiratory syndrome coronavirus infection in camel workers in Qatar during 2013–2014: a case–control study. J Infect Dis 215:1702–1705
To KK, Ng KH, Que TL, Chan JM, Tsang KY, Tsang AK, Chen H, Yuen KY (2012) Avian influenza A H5N1 virus: a continuous threat to humans. Emerg Microbes Infect 1:e25
ICTV (2018) International committee on taxonomy of viruses, 10th report. https://talk.ictvonline.org/taxonomy/. Accessed 25 Jan 2019
Tong S, Tian J, Wang H, Huang Z, Yu M, Sun L, Liu R, Liao M, Ning Z (2013) H9N2 avian influenza infection altered expression pattern of sphiogosine-1-phosphate receptor 1 in BALB/c mice. Virol J 10:296
Mancini DA, Mendonca RM, Pereira AS, Kawamoto AH, Vannucchi CI, Pinto JR, Mori E, Mancini Filho J (2012) Influenza viruses in adult dogs raised in rural and urban areas in the state of Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo 54:311–314
Swayne DE, King DJ (2003) Avian influenza and Newcastle disease. J Am Vet Med Assoc 222:1534–1540
Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB (2007) The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25:5086–5096
Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, Lopez-Gatell H, Olivera H, Lopez I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197–201
Parry J (2013) H7N9 avian flu infects humans for the first time. BMJ 346:f2151
To KK, Tsang AK, Chan JF, Cheng VC, Chen H, Yuen KY (2014) Emergence in China of human disease due to avian influenza A(H10N8)—cause for concern? J Infect 68:205–215
Arabia MoHS (2017) Influenza Surveillance in Saudi Arabia, available at https://www.moh.gov.sa/CCC/healthp/regulations/Documents/ISSA%20Protocol.pdf. Accessed 13 Dec 2018
Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, Finelli L (2009) Estimates of the prevalence of pandemic (H1N1) 2009, United States, April–July 2009. Emerg Infect Dis 15:2004–2007
AlMazroa MA, Memish ZA, AlWadey AM (2010) Pandemic influenza A (H1N1) in Saudi Arabia: description of the first one hundred cases. Ann Saudi Med 30:11–14
BinSaeed AA (2010) Characteristics of pandemic influenza A (H1N1) infection in patients presenting to a university hospital in Riyadh, Saudi Arabia. Ann Saudi Med 30:59–62
Al Subaie SS, Al Saadi MA (2012) Features associated with severe disease in hospitalized children with 2009 influenza A (H1N1) infection at a university hospital in Riyadh, Saudi Arabia. Ann Saudi Med 32:53–58
Affifi RM, Omar SR, El Raggal AA (2012) A novel influenza A (H1N1) outbreak experience among residents of a long term-care facility in Saudi Arabia during 2010 seasonal flu circulation. Infect Dis Rep 4:e23
Altayep KM, Ahmed HG, Tallaa AT, Alzayed AS, Alshammari AJ, Ali Talla AT (2017) Epidemiology and clinical complication patterns of influenza A (H1N1 virus) in Northern Saudi Arabia. Infect Dis Rep 9:6930
Balkhy HH, El-Saed A, Sallah M (2010) Epidemiology of H1N1 (2009) influenza among healthcare workers in a tertiary care center in Saudi Arabia: a 6-month surveillance study. Infect Control Hosp Epidemiol 31:1004–1010
Agha A, Alrawi A, Munayco CV, Alayed MS, Al-Hakami M, Korairi H, Bella A (2012) Characteristics of patients hospitalized with 2009 H1N1 influenza in a tertiary care hospital in southern Saudi Arabia. Mediterr J Hematol Infect Dis 4:e2012002
Al-Tawfiq JA, Abed M, Saadeh BM, Ghandour J, Shaltaf M, Babiker MM (2011) Pandemic influenza A (2009 H1N1) in hospitalized patients in a Saudi Arabian hospital: epidemiology and clinical comparison with H1N1-negative patients. J Infect Public Health 4:228–234
de la Torre JC (1994) Molecular biology of borna disease virus: prototype of a new group of animal viruses. J Virol 68:7669–7675
Feldmann H, Klenk HD (1996) Marburg and Ebola viruses. Adv Virus Res 47:1–52
Huang YT, Wertz GW (1982) The genome of respiratory syncytial virus is a negative-stranded RNA that codes for at least seven mRNA species. J Virol 43:150–157
Collins PL, Hill MG, Cristina J, Grosfeld H (1996) Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proc Natl Acad Sci USA 93:81–85
Mufson MA, Orvell C, Rafnar B, Norrby E (1985) Two distinct subtypes of human respiratory syncytial virus. J Gen Virol 66(Pt 10):2111–2124
Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O’Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C, Simoes EA, Rudan I, Weber MW, Campbell H (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375:1545–1555
Paramore LC, Ciuryla V, Ciesla G, Liu L (2004) Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics 22:275–284
Abraha HY, Lanctôt KL, Paes B (2015) Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention. Expert Rev Respir Med 9:779–799
Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H, Group WHOCHER (2004) Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ 82:895–903
Weber MW, Mulholland EK, Greenwood BM (1998) Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health 3:268–280
Reeves RM, Hardelid P, Gilbert R, Warburton F, Ellis J, Pebody RG (2017) Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007-2012. Influenza Other Respir Viruses 11:122–129
Hall CB (2001) Respiratory syncytial virus and parainfluenza virus. N Engl J Med 344:1917–1928
Walsh EE, Falsey AR (2012) Respiratory syncytial virus infection in adult populations. Infect Disord Drug Targets 12:98–102
Fodha I, Vabret A, Trabelsi A, Freymuth F (2004) Epidemiological and antigenic analysis of respiratory syncytial virus in hospitalised Tunisian children, from 2000 to 2002. J Med Virol 72:683–687
Waris M (1991) Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with alternating prevalence of groups A and B. J Infect Dis 163:464–469
Rajala MS, Sullender WM, Prasad AK, Dar L, Broor S (2003) Genetic variability among Group A and B respiratory syncytial virus isolates from a large referral hospital in New Delhi, India. J Clin Microbiol 41:2311–2316
Trento A, Abrego L, Rodriguez-Fernandez R, Gonzalez-Sanchez MI, Gonzalez-Martinez F, Delfraro A, Pascale JM, Arbiza J, Melero JA (2015) Conservation of G-Protein Epitopes in Respiratory Syncytial Virus (Group A) Despite Broad Genetic Diversity: Is Antibody Selection Involved in Virus Evolution? J Virol 89:7776–7785
Eshaghi A, Duvvuri VR, Lai R, Nadarajah JT, Li A, Patel SN, Low DE, Gubbay JB (2012) Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication. PLoS One 7:e32807
Al-Alaiyan S, Pollack P, Notario GF (2015) Safety and pharmacokinetics of extended use of palivizumab in Saudi Arabian infants and children. Drugs Context 4:212270. https://doi.org/10.7573/dic.212270
Bakir TM, Halawani M, Ramia S (1998) Viral aetiology and epidemiology of acute respiratory infections in hospitalized Saudi children. J Trop Pediatr 44:100–103
Henrickson KJ (2003) Parainfluenza viruses. Clin Microbiol Rev 16:242–264
Cortez KJ, Erdman DD, Peret TC, Gill VJ, Childs R, Barrett AJ, Bennett JE (2001) Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population. J Infect Dis 184:1093–1097
Aguilar JC, Perez-Brena MP, Garcia ML, Cruz N, Erdman DD, Echevarria JE (2000) Detection and identification of human parainfluenza viruses 1, 2, 3, and 4 in clinical samples of pediatric patients by multiplex reverse transcription-PCR. J Clin Microbiol 38:1191–1195
Lau SK, To WK, Tse PW, Chan AK, Woo PC, Tsoi HW, Leung AF, Li KS, Chan PK, Lim WW, Yung RW, Chan KH, Yuen KY (2005) Human parainfluenza virus 4 outbreak and the role of diagnostic tests. J Clin Microbiol 43:4515–4521
Templeton KE, Bredius RG, Claas EC, Kroes AC, Walther FJ (2005) Parainfluenza virus 4 detection in infants. Eur J Pediatr 164:528–529
Glezen WP, Frank AL, Taber LH, Kasel JA (1984) Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis 150:851–857
Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ (1999) Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 282:1440–1446
Counihan ME, Shay DK, Holman RC, Lowther SA, Anderson LJ (2001) Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States. Pediatr Infect Dis J 20:646–653
Iwane MK, Edwards KM, Szilagyi PG, Walker FJ, Griffin MR, Weinberg GA, Coulen C, Poehling KA, Shone LP, Balter S, Hall CB, Erdman DD, Wooten K, Schwartz B, New Vaccine Surveillance N (2004) Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 113:1758–1764
Laurichesse H, Dedman D, Watson JM, Zambon MC (1999) Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975-1997. Eur J Epidemiol 15:475–484
Wang F, Zhao LQ, Zhu RN, Deng J, Sun Y, Ding YX, Tian R, Qian Y (2015) Parainfluenza Virus Types 1, 2, and 3 in Pediatric Patients with Acute Respiratory Infections in Beijing During 2004 to 2012. Chin Med J (Engl) 128:2726–2730
Liu WK, Liu Q, Chen DH, Liang HX, Chen XK, Huang WB, Qin S, Yang ZF, Zhou R (2013) Epidemiology and clinical presentation of the four human parainfluenza virus types. BMC Infect Dis 13:28
Al-Hajjar S, Akhter J, Al Jumaah S, Hussain Qadri SM (1998) Respiratory viruses in children attending a major referral centre in Saudi Arabia. Ann Trop Paediatr 18:87–92
Alshehri MA, Almegamesi TM, Alfrayh AS (2005) Predictors of short-term hospital readmissions of asthmatic children. J Fam Commun Med 12:11–17
Meqdam MM, Subaih SH, Thwiny IR (2005) Rapid detection and clinical features of influenza and parainfluenza in infants and young children hospitalized with acute lower respiratory illnesses. J Trop Pediatr 51:160–165
Legrand L, Vabret A, Dina J, Petitjean-Lecherbonnier J, Stephanie G, Cuvillon D, Tripey V, Brouard J, Freymuth F (2011) Epidemiological and phylogenic study of human metapneumovirus infections during three consecutive outbreaks in Normandy, France. J Med Virol 83:517–524
Maggi F, Pifferi M, Vatteroni M, Fornai C, Tempestini E, Anzilotti S, Lanini L, Andreoli E, Ragazzo V, Pistello M, Specter S, Bendinelli M (2003) Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy. J Clin Microbiol 41:2987–2991
Al Hajjar S, Al Thawadi S, Al Seraihi A, Al Muhsen S, Imambaccus H (2011) Human metapneumovirus and human coronavirus infection and pathogenicity in Saudi children hospitalized with acute respiratory illness. Ann Saudi Med 31:523–527
Al-Ayed MS, Asaad AM, Qureshi MA, Ameen MS (2014) Viral etiology of respiratory infections in children in southwestern Saudi Arabia using multiplex reverse-transcriptase polymerase chain reaction. Saudi Med J 35:1348–1353
Greenberg SB (2011) Update on rhinovirus and coronavirus infections. Semin Respir Crit Care Med 32:433–446
Jansen RR, Wieringa J, Koekkoek SM, Visser CE, Pajkrt D, Molenkamp R, de Jong MD, Schinkel J (2011) Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J Clin Microbiol 49:2631–2636
Tregoning JS, Schwarze J (2010) Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 23:74–98
Al-Ghamdi SM, Akbar HO, Qari YA, Fathaldin OA, Al-Rashed RS (2003) Pattern of admission to hospitals during muslim pilgrimage (Hajj). Saudi Med J 24:1073–1076
Baharoon S, Al-Jahdali H, Al Hashmi J, Memish ZA, Ahmed QA (2009) Severe sepsis and septic shock at the Hajj: etiologies and outcomes. Travel Med Infect Dis 7:247–252
Mandourah Y, Al-Radi A, Ocheltree AH, Ocheltree SR, Fowler RA (2012) Clinical and temporal patterns of severe pneumonia causing critical illness during Hajj. BMC Infect Dis 12:117
Memish ZA, Assiri A, Almasri M, Alhakeem RF, Turkestani A, Al Rabeeah AA, Akkad N, Yezli S, Klugman KP, O’Brien KL, van der Linden M, Gessner BD (2015) Impact of the Hajj on pneumococcal transmission. Clin Microbiol Infect 21(77):e11–e78
Al-Tawfiq JA, Benkouiten S, Memish ZA (2018) A systematic review of emerging respiratory viruses at the Hajj and possible coinfection with Streptococcus pneumoniae. Travel Med Infect Dis 23:6–13
Memish ZA, Assiri A, Almasri M, Alhakeem RF, Turkestani A, Al Rabeeah AA, Al-Tawfiq JA, Alzahrani A, Azhar E, Makhdoom HQ, Hajomar WH, Al-Shangiti AM, Yezli S (2014) Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj. J Infect Dis 210:1067–1072
Aberle JH, Popow-Kraupp T, Kreidl P, Laferl H, Heinz FX, Aberle SW (2015) Influenza A and B Viruses but Not MERS-CoV in Hajj Pilgrims, Austria, 2014. Emerg Infect Dis 21:726–727
Koul PA, Mir H, Saha S, Chadha MS, Potdar V, Widdowson MA, Lal RB, Krishnan A (2017) Influenza not MERS CoV among returning Hajj and Umrah pilgrims with respiratory illness, Kashmir, north India, 2014–15. Travel Med Infect Dis 15:45–47
Ma X, Liu F, Liu L, Zhang L, Lu M, Abudukadeer A, Wang L, Tian F, Zhen W, Yang P, Hu K (2017) No MERS-CoV but positive influenza viruses in returning Hajj pilgrims, China, 2013–2015. BMC Infect Dis 17:715
Al-Abdallat MM, Rha B, Alqasrawi S, Payne DC, Iblan I, Binder AM, Haddadin A, Nsour MA, Alsanouri T, Mofleh J, Whitaker B, Lindstrom SL, Tong S, Ali SS, Dahl RM, Berman L, Zhang J, Erdman DD, Gerber SI (2017) Acute respiratory infections among returning Hajj pilgrims-Jordan, 2014. J Clin Virol 89:34–37
Refaey S, Amin MM, Roguski K, Azziz-Baumgartner E, Uyeki TM, Labib M, Kandeel A (2017) Cross-sectional survey and surveillance for influenza viruses and MERS-CoV among Egyptian pilgrims returning from Hajj during 2012–2015. Influenza Other Respir Viruses 11:57–60
Barasheed O, Rashid H, Alfelali M, Tashani M, Azeem M, Bokhary H, Kalantan N, Samkari J, Heron L, Kok J, Taylor J, El Bashir H, Memish ZA, Haworth E, Holmes EC, Dwyer DE, Asghar A, Booy R, Hajj Research T (2014) Viral respiratory infections among Hajj pilgrims in 2013. Virol Sin 29:364–371
Al-Tawfiq JA, Gautret P, Memish ZA (2017) Expected immunizations and health protection for Hajj and Umrah 2018 -An overview. Travel Med Infect Dis 19:2–7
Ashshi A, Azhar E, Johargy A, Asghar A, Momenah A, Turkestani A, Alghamdi S, Memish Z, Al-Ghamdi A, Alawi M, El-Kafrawy S, Farouk M, Harakeh S, Kumosani T, Makhdoum H, Barbour EK (2014) Demographic distribution and transmission potential of influenza A and 2009 pandemic influenza A H1N1 in pilgrims. J Infect Dev Ctries 8:1169–1175
Khan K, Memish ZA, Chabbra A, Liauw J, Hu W, Janes DA, Sears J, Arino J, Macdonald M, Calderon F, Raposo P, Heidebrecht C, Wang J, Chan A, Brownstein J, Gardam M (2010) Global public health implications of a mass gathering in Mecca, Saudi Arabia during the midst of an influenza pandemic. J Travel Med 17:75–81
Rashid H, Shafi S, Booy R, El Bashir H, Ali K, Zambon M, Memish Z, Ellis J, Coen P, Haworth E (2008) Influenza and respiratory syncytial virus infections in British Hajj pilgrims. Emerg Health Threats J 1:e2
Yavarian J, Shafiei Jandaghi NZ, Naseri M, Hemmati P, Dadras M, Gouya MM, Mokhtari Azad T (2018) Influenza virus but not MERS coronavirus circulation in Iran, 2013-2016: Comparison between pilgrims and general population. Travel Med Infect Dis 21:51–55
Gautret P, Benkouiten S, Al-Tawfiq JA, Memish ZA (2016) Hajj-associated viral respiratory infections: a systematic review. Travel Med Infect Dis 14:92–109
Moattari A, Emami A, Moghadami M, Honarvar B (2012) Influenza viral infections among the Iranian Hajj pilgrims returning to Shiraz, Fars province, Iran. Influenza Other Respir Viruses 6:e77–e79
Rashid H, Shafi S, Haworth E, El Bashir H, Memish ZA, Sudhanva M, Smith M, Auburn H, Booy R (2008) Viral respiratory infections at the Hajj: comparison between UK and Saudi pilgrims. Clin Microbiol Infect 14:569–574
Haworth E, Rashid H, Booy R (2010) Prevention of pandemic influenza after mass gatherings—learning from Hajj. J R Soc Med 103:79–80
Mandourah Y, Ocheltree A, Al Radi A, Fowler R (2012) The epidemiology of Hajj-related critical illness: lessons for deployment of temporary critical care services. Crit Care Med 40:829–834
Alzeer AH (2009) Respiratory tract infection during Hajj. Ann Thorac Med 4:50–53
Annan A, Owusu M, Marfo KS, Larbi R, Sarpong FN, Adu-Sarkodie Y, Amankwa J, Fiafemetsi S, Drosten C, Owusu-Dabo E, Eckerle I (2015) High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013. Trop Med Int Health 20:807–812
Balkhy HH, Memish ZA, Bafaqeer S, Almuneef MA (2004) Influenza a common viral infection among Hajj pilgrims: time for routine surveillance and vaccination. J Travel Med 11:82–86
Al-Tawfiq JA, Memish ZA (2012) Mass gatherings and infectious diseases: prevention, detection, and control. Infect Dis Clin North Am 26:725–737
Gautret P, Bauge M, Simon F, Benkouiten S, Parola P, Brouqui P (2012) Travel reported by pilgrims from Marseille, France before and after the 2010 Hajj. J Travel Med 19:130–132
Benkouiten S, Charrel R, Belhouchat K, Drali T, Salez N, Nougairede A, Zandotti C, Memish ZA, Al Masri M, Gaillard C, Parola P, Brouqui P, Gautret P (2013) Circulation of respiratory viruses among pilgrims during the 2012 Hajj pilgrimage. Clin Infect Dis 57:992–1000
Atabani SF, Wilson S, Overton-Lewis C, Workman J, Kidd IM, Petersen E, Zumla A, Smit E, Osman H (2016) Active screening and surveillance in the United Kingdom for Middle East respiratory syndrome coronavirus in returning travellers and pilgrims from the Middle East: a prospective descriptive study for the period 2013–2015. Int J Infect Dis 47:10–14
Jamjoom GA, Al-Semrani AM, Board A, Al-Frayh AR, Artz F, Al-Mobaireek KF (1993) Respiratory syncytial virus infection in young children hospitalized with respiratory illness in Riyadh. J Trop Pediatr 39:346–349
Chowdhury D, Al-Howasi M, Ramia S, Al-Frayh AR, Khalil M, Chowdhury S (1996) Respiratory syncytial virus in Saudi patients admitted to hospital with bronchiolitis: Use of direct fluorescent antibody tests as a rapid diagnostic tool. Ann Saudi Med 16:90–92
Kilani RA (2002) Respiratory syncytial virus (RSV) outbreak in the NICU: description of eight cases. J Trop Pediatr 48:118–122
Mb SM (2005) Respiratory syncytial virus infection in patients visiting King Khaled university hospital. Minoufia Med J 18(18):11–18
Meqdam MM, Subaih SH (2006) Rapid detection and clinical features of infants and young children with acute lower respiratory tract infection due to respiratory syncytial virus. FEMS Immunol Med Microbiol 47:129–133
Akhter JAJSDF, Al Hefdi R, Al Hassan I (2009) Etiology of respiratory viral infections using rapid virus isolation methods at a tertiary care center in Riyadh, Saudi Arabia. Saudi Pharm J 17:177–181
Almajhdi FNAA-JME, Latif A, Gissmann L, Amer Haitham M (2009) Prevalence of respiratory syncytial virus infection in Riyadh during the winter season 2007–2008 and different risk factors impact. Int J Virol 5:154–163
Memish ZA, Assiri AM, Hussain R, Alomar I, Stephens G (2012) Detection of respiratory viruses among pilgrims in Saudi Arabia during the time of a declared influenza A(H1N1) pandemic. J Travel Med 19:15–21
Ahmed A, Haider SH, Parveen S, Arshad M, Alsenaidy HA, Baaboud AO, Mobaireek KF, AlSaadi MM, Alsenaidy AM, Sullender W (2016) Co-circulation of 72bp duplication group A and 60bp duplication group B respiratory syncytial virus (RSV) strains in Riyadh, Saudi Arabia during 2014. PLoS One 11:e0166145
Abdulhaq AA, Basode VK, Hashem AM, Alshrari AS, Badroon NA, Hassan AM, Alsubhi TL, Solan Y, Ejeeli S, Azhar EI (2017) Patterns of human respiratory viruses and lack of MERS-coronavirus in patients with acute upper respiratory tract infections in Southwestern Province of Saudi Arabia. Adv Virol 2017:4247853
Albogami SS, Alotaibi MR, Alsahli SA, Masuadi E, Alshaalan M (2018) Seasonal variations of respiratory viruses detected from children with respiratory tract infections in Riyadh, Saudi Arabia. J Infect Public Health 11:183–186
Abdel-Moneim AS, Kamel MM, Al-Ghamdi AS, Al-Malky MI (2013) Detection of bocavirus in children suffering from acute respiratory tract infections in Saudi Arabia. PLoS One 8:e55500
Ali M, Han S, Gunst CJ, Lim S, Luinstra K, Smieja M (2015) Throat and nasal swabs for molecular detection of respiratory viruses in acute pharyngitis. Virol J 12:178
El-Sheikh SM, El-Assouli SM, Mohammed KA, Albar M (1998) Bacteria and viruses that cause respiratory tract infections during the pilgrimage (Haj) season in Makkah, Saudi Arabia. Trop Med Int Health 3:205–209
Acknowledgment
The authors thank the Deanship of Scientific Research and RSSU at King Saud University for their technical support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Handling Editor: Carolina Scagnolari.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Farrag, M.A., Hamed, M.E., Amer, H.M. et al. Epidemiology of respiratory viruses in Saudi Arabia: toward a complete picture. Arch Virol 164, 1981–1996 (2019). https://doi.org/10.1007/s00705-019-04300-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-019-04300-2